Showing posts with label researchers. Show all posts
Showing posts with label researchers. Show all posts

Tuesday, 12 January 2021

Holding breath may increase risk of getting COVID-19 infection : IIT Madras researchers




Holding breath may increase risk of getting COVID-19 infection : IIT Madras researchers


Biswabrata Goswami

Hummingbird News

CHENNAI, 11 JAN: Indian Institute of Technology, Madras (IIT-Madras) researchers have found that the process of virus-laden droplets being transported into deep lung increases with decreasing breathing frequency.

The research team modelled the breathing frequency in a laboratory and found that low breathing frequency increases the time of residence of the virus and therefore it increases chances of deposition and consequently the infection. Also, the multi-scale lung structure has a significant effect on a person’s susceptibility to COVID-19.

The research was led by Prof. Mahesh Panchagnula, Department of Applied Mechanics, IIT Madras, with his research scholars Mr. Arnab Kumar Mallik and Mr. Soumalya Mukherjee, IIT Madras. The findings of this study were published in the international reputed peer-reviewed journal Physics of Fluids.

Elaborating on the need for such research, Prof. Mahesh Panchagnula, Department of Applied Mechanics, IIT Madras, said, “COVID-19 (the disease caused by Coronavirus) has opened a gap in our understanding of deep pulmonological systemic diseases. Our study unravels the mystery behind how particles are transported and deposited in the deep lung. The study demonstrates the physical process by which aerosol particles are transported into the deep generations of the lung.”

Prof. Mahesh V. Panchagnula’s team worked to gain a deeper understanding of how the rate of flow of droplet laden with virus determines the deposition of the virus in the lungs. In their research, the team reported that holding the breath and having low breathing rate can increase chances of virus deposition in the lungs. The study was conducted to pave the way for developing better therapies and drugs for respiratory infections. Previous work from the group has also highlighted the significant variability in aerosol uptake from individual to individual, suggesting a reason why some people are more susceptible to airborne diseases than others.

Airborne infections such as Coronavirus spread immensely through sneezing and coughing as it instantly releases a lot of tiny droplets. The IIT Madras Research team imitated the droplet dynamics in the lung by studying the movement of droplets in the small capillaries which were of a diameter similar to bronchioles. They took water mixed with fluorescent particles and generated aerosols from this liquid using a nebulizer. These fluorescent aerosols were used to track the movement and deposition of particles in the capillaries.

The researchers studied the movement of the fluorescentaerosol particlesin capillaries of size ranging from 0.3 to 2 millimetres which covers the range of bronchiole diameters. They found that the deposition is inversely proportional to the aspect ratio of capillaries, which suggests that the droplets are likely to deposit in longer bronchioles.

The scientists also studied how the ‘Reynolds Number,’ a parameter that quantifies the nature of flow - steady or turbulent, determines the deposition in the capillaries. They found that when the flow of aerosol movement is steady then the particles deposit via the process of diffusion, however, if the flow is turbulent then the particles deposit via the process of impaction.

In future, the team intends to continue this work to understand how the virus-laden droplets are transported into lungs as the process by which the virus is transported from the nasal cavity to the deep lung is still unknown. An understanding of the physics of this phenomenon could be crucial in mitigating the progression of the disease.

Saturday, 24 October 2020

Coronavirus : ICMR approves low-cost testing method developed by IIT-Kharagpur



Coronavirus : ICMR approves low-cost testing method developed by IIT-Kharagpur


This new testing method implements a highly reliable & accurate molecular diagnostic procedure, conducted in an ultra-low-cost portable device unit & costs only around Rs. 500 per test 



Biswabrata Goswami  

Hummingbird News

KHARAGPUR, 21 October: IIT Kharagpur researchers have developed a diagnostic machine named ‘COVIRAP,’ the diagnostic machine, which has been successfully validated for its efficacy in COVID-19 detection by the Indian Council of Medical Research (ICMR).

Various commercial units have already approached the Institute for technology licensing to enable a rapid reach of this innovation to the common people.

This test has been designed to be fairly easy to conduct and affordable as well and can produce results in a custom-developed mobile phone application within one hour.

It has an automated pre-programmable temperature control unit, a special detection unit on genomic analysis, and a customised smartphone app for results.

Three master mixes work as markers of different genes to confirm the presence of SARS-CoV-2, said Prof Suman Chakraborty, Dean, Sponsored Research and Industrial Consultancy, IIT Kharagpur. Samples collected react with these mixes. When paper strips are dipped into these reaction products, coloured lines indicate the presence of the virus.

Dr Arindam Mondal, Assistant Professor, School of Bioscience, IIT-KGP, said the technology has been subjected to rigorous testing protocols as per ICMR guidelines.

Addressing a Virtual Press Conference on 21 October, to announce this major development in the nation’s fight against COVID-19, Dr. Ramesh Pokhriyal Nishank, Minister of Education, Government of India, said, “I am glad the researchers from IIT Kharagpur have achieved the goal of Atmanirbhar Bharat through this medical technology innovation. This would go on impacting the lives of many in rural India as the device is portable and can be operated on a very low energy supply. Minimally trained rural youth can operate this device.” 

Further, Dr. Ramesh Pokhriyal Nishank, said, “This innovation has made high-quality and accurate COVID testing affordable for the common people with a testing cost of around ₹ 500/- which can further be reduced through government intervention. As informed by IIT Kharagpur, this machine can be developed at a cost of less than ₹ 10,000/- with minimal infrastructural requirement making the technology affordable to common people. The testing process in this new machine is completed within one hour. I congratulate Prof. V.K. Tewari, Director, IIT Kharagpur, and the research team led by Prof. Suman Chakraborty and Dr. Arindam Mondal for this path-breaking innovation taking molecular diagnostics from high-end labs to the field.”

Speaking about this test, Prof. V.K. Tewari, Director, IIT Kharagpur, said, “This is indeed one of the greatest contributions in the history of medical science, particularly in the area of virology, and is well set to replace PCR-based tests to a large extent.”

Subsequent financial support to this project was provided by the IIT Foundation, USA, to meet the various expenses in the clinical testing phase. Partial financial support has also been provided from the Common Research and Technology Development Hub on Affordable Healthcare, established by Council of Scientific and Industrial Research (CSIR), Government of India, at IIT Kharagpur.

Elaborating on the validation process of ‘COVIRAP’ Diagnostic Test, Dr. Mamta Chawla Sarkar, an Internationally acclaimed virologist who oversaw the patient trials on behalf of ICMR-National Institute of Cholera and Enteric Diseases (NICED) said, “A detailed scrutiny of the testing results has clearly shown that this assay holds the capability of detecting extremely low levels of viral loads that any other method based on similar principles of testing, even those from the most celebrated research groups across the world, could not come up with so far. In practice, this means that very early stages of infection can be detected, thereby isolating the patient and arresting the uncontrolled spread of infection in the community via asymptomatic patients.”

Further, Dr. Shanta Dutta, Director of ICMR-NICED added, “While overseeing the testing and validation, I was very impressed with the portable low-cost machine unit that can truly be a game-changer for COVID-19 diagnostics at peripheral laboratories with the support of unskilled human resources as operators. This now needs a rapid commercial scale-up to cater to the needs of the underserved population.  ICMR-NICED will be pleased to facilitate support for further improvisations in the method towards even superior performance.”

The novel diagnostic platform, developed by a team of researchers lead by Prof. Suman Chakraborty, Professor, Department of Mechanical Engineering, IIT Kharagpur, and Dr. Arindam Mondal, Assistant Professor, School of Bio-Science, IIT Kharagpur, has been subjected to rigorous testing protocols as per ICMR guidelines, at ICMR-NICED, an Institute authorized by ICMR. The tests conducted there have revealed that the results from this new assay are of standards comparable to the celebrated RT-PCR tests, with a remarkably high level of specificity and sensitivity, the two common parameters used as indicators of efficacy of any diagnostic test.

ICMR-NICED has further certified the test to be extremely user-friendly. Notably, the number of tests per one-hour batch in a single machine unit can be further increased to much higher limits, for the purpose of testing on a mass scale.

Elaborating on this test, Prof. Suman Chakraborty, Professor, Department of Mechanical Engineering Department, IIT Kharagpur, said, “The patented machine unit has not only been proven to be robust during patient sample testing but also extremely flexible and generic. This means that other than COVID-19 testing, many other tests, falling under the category of ‘isothermal nucleic acid-based tests’ (INAT), can be performed in the same machine. In other words, influenza, malaria, dengue, Japanese encephalitis, tuberculosis and many other infectious, as well as vector-borne diseases, can be tested using the same machine. This will virtually minimize the need for thermal cyclers or real-time PCR machines, without sacrificing the expected high standards of a molecular diagnostic test.”

Further, Dr. Arindam Mondal, Assistant Professor, School of Biosciences, IIT Kharagpur, said, “During the testing phase of patient samples, all kits, exclusively developed at IIT Kharagpur, were transported in an uncontrolled environment for hours to the testing unit, which shows high levels of stability of the reagents that are being used for the testing.”

Speaking about the commercialization of ‘COVIRAP,’ Prof. V.K. Tewari, Director, IIT Kharagpur, said, “While the Institute can produce the testing kit up to a certain scale, patent licensing will facilitate commercialization opportunities for medical technology companies. Any corporate or start-up can approach the Institute for technology licensing and commercial scale of production. The Institute is open to tie-ups, with due measures of protecting the interest of public health amidst the pandemic situation.”

“Today, it is COVID-19; yesterday, it was leprosy and tuberculosis; tomorrow, it will be something else. This technology is all set to create a revolution in rapid and low-cost detection of all these, by bringing high-end molecular diagnostics from the lab to the field. The impact of this, therefore, is long-lasting, empowered by the capability of detecting unforeseen pandemics in the coming years that may potentially endanger human lives time and again,” remarked Prof. Suman Chakraborty.

Saturday, 25 July 2020

IIT-Kharagpur researchers develop ultra-low-cost portable first-of-its-kind device for Covid-19 rapid test






IIT-Kharagpur researchers develop ultra-low-cost portable first-of-its-kind device for Covid-19 rapid test

The entire rapid test can be conducted in an ultra-low-cost portable device with the test results available in a customized smartphone application for dissemination within 1 hour without requiring manual interpretation. All of this at a cost of around INR 400/- per test.
         
 Biswabrata Goswami

 Hummingbird News



KHARAGPUR, 25 JULY: In a unique effort, researchers at IIT Kharagpur have innovated a novel portable rapid diagnostic device to detect COVID-19 infection. This first-of-its-kind device will bring the testing for COVID-19 out from the walls of expensive laboratories and RT-PCR machines and enable testing at affordable costs for the under-served community across the world.
This entire test with the extracted RNA from the patient saliva samples can be conducted in an ultra-low-cost portable enclosure as an alternative to specialized laboratory equipment. The same portable unit can be used for a large number of tests, on mere replacement of the paper cartridge after each test. The device has been proven to produce no false result with remarkable accuracy and sensitivity compatible to standard RT-PCR tests.
This test has an unprecedented low cost of less than Rs 400/- per test, taking all components of expenses and business model into account.
Considering the impending outbreak of COVID-19 infection at progressively more geographical locations with the anticipated increment in number of affected personnel at a dramatic rate, there is an emergent need to run large numbers of reliable diagnostic tests at affordable cost and minimal infrastructural support, for monitoring the early stages of progression of the disease when many of the infected persons do not exhibit discernible symptoms of infection.
A team of researchers from IIT Kharagpur, contemplating on the challenge, realized the alternative cannot be new innovations for the existing detection systems such as testing kits and PCR machines but a disruptive approach leading to a new technology and testing process being innovated without sacrificing the scientific rigor and medically acceptable high standards of the test results.
The research team has successfully validated the detection procedure, taking time of approximately 60 minutes to run each test. 
This obviates the need of an expensive PCR machine, by means of a set of innovations such as a portable automated pre-programmable temperature control unit for the genomic analysis, coupled with a specially functionalized detection unit on a simple strip of paper, and a customized smartphone application for dissemination of test results without requiring manual interpretation. While the Institute can produce the testing kit up to a certain scale, patent licensing will facilitate commercialization opportunities for medical technology companies.
Under the guidance of the Professors, the device design and fabrication work has been spearheaded by doctoral student Mr. Sujay Kumar Biswas, and the bio-analytical protocol has been standardized by doctoral students Mr. Saptarshi Banerjee and Ms. Nandita Kedia. Dr. Aditya Bandopahyay has further helped in developing the thermal unit.
Highlighting the need for such equipment, Prof. Suman Chakraborty, Department of Mechanical Engineering, IIT Kharagpur, said, “In assessing the utility of a specific method of disease detection, there is a common failure to recognize that the cost of the test kit may not turn out to be the most critical factor from the viewpoint of affordable diagnosis, unlike what is being commonly portrayed. Rather, the greater challenge is complete elimination of the need for any specialized infrastructure and ensuring the possibility of conducting tests at large scale at low cost without compromised accuracy. In that light, the RT-PCR based tests suffer from a compelling constraint of requiring an elaborate laboratory-infrastructure and support system including the operational and maintenance cost, to perform the test. The alternative existing approaches to these tests, on the other hand, are either invasive (blood tests) and non-indicative of early stage of development of the infection, or dependent on reagents that are extremely unstable and cannot be implemented in resource-limited settings.”

The Equipment developed by IIT Kharagpur Researchers will cost about ₹ 2,000 if a pilot facility is used. Use of a large-scale commercial facility will further reduce with increase in the production scale. This compares very favourably with the RT PCR machine costing ₹ 15 Lakh.
Further, Dr. Arindam Mondal, Assistant Professor, School of Bio Science, IIT Kharagpur, added, “The unique portable device developed by the IIT Kharagpur researchers has not only been validated for the diagnostics of COVID-19, but also been designed to be capable of detecting any other kind of RNA virus by following the same generic procedure. The impact of this, therefore, is long lasting, empowered by the capability of detecting unforeseen viral pandemics in the coming years that may potentially endanger human lives time and again.”
The project received financial support from the Institute in late April as Prof. V K Tewari, Director, IIT Kharagpur, decided to set up a fund to support COVID-19 related research and product development.
“This unique innovation is aligned with the Institutional vision to develop high-end healthcare technologies that can be afforded by the ailing common people all around the globe at virtually no cost, and is likely to make significant breakthrough in global viral pandemic management”, opined Director Prof. V K Tewari.
The Ministry of Human Resources Development, Govt. of India has also been reaching out to all technical institutions regarding ongoing research work to help address India's increasing need to augment testing facilities.
The results from this new technology have been strictly validated by following all established laboratory controls against the benchmarked results obtained from RT-PCR machine, using synthetic viral RNA. The synthetic RNA is exactly the same replicate of the viral RNA extracted from infected patients, as per accepted scientific benchmarking procedure, and is used for validating laboratory tests to avoid undue contamination and danger due to spreading of infection while handling sensitive body-fluid samples.
IIT Kharagpur is ready for commercialization of the product. Any corporate or start-up can approach the Institute for technology licensing and commercial scale of production. The Institute is open to tie-ups, including a mode where the government intervenes with regards to meeting our low-cost healthcare objective for the under-served community as a policy measure to protect the interest of public health amidst the pandemic situation, instead of merely developing a strong profit-oriented model.